According to Michael Belkin, an investment analyst who has gained a glowing reputation, the stock-market rally is destined to take a plunge. He describes his long and short strategies for the coming months.
MSN.com October 22, 2003
Michael Belkin is a financial analyst whose daughter died a number of years ago from hepatitis B vaccine. Because of his prominence he has been able to testify before Congress on this issue.
Michael has been a valuable resource to me, exposing me to loads of health information. Although the story below has nothing to do with health, I thought some of you might be interested in what Michael does to earn his living and might actually benefit from his future financial projections. Now, I just have to figure out how I can charge $36,000 a year for my newsletter like Michael does (just kidding -- mine is and will remain free!).
Related Articles:
Financial Burdens Add to Stress of Terminal